A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables

BMC Medical Genomics

Volumn 6, Issue SUPPL. 3, 2013, Pages

  Wang, Mengjun ^a   Mehta, Anand ^a   Block, Timothy M ^a   Marrero, Jorge ^b   Di Bisceglie, Adrian M ^c   Devarajan, Karthik ^d  

^a 3912 Taubman Center ^*  (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; BIOLOGICAL MARKER; KININOGEN;

ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER RESEARCH; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FUCOSYLATION; GENDER; GOLGI COMPLEX; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MODEL BASED CLASSIFICATION AND REGRESSION TREE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; STEPWISE PENALIZED LOGISTIC REGRESSION;

AGE FACTORS; ALGORITHMS; ALPHA 1-ANTITRYPSIN; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; FUCOSE; HUMANS; KININOGENS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ROC CURVE; SEX FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84887975088     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-S3-S9     Document Type: Article

References (26)

1. Hepatocellular carcinoma: molecular biology of its growth and relationship to hepatitis B virus infection. Di Bisceglie AM, Med Clin North Am 1989 73 985 97 2542706 (Pubitemid 19163735)
2. Molecular viral oncology of hepatocellular carcinoma. Block TM, Mehta AS, Fimmel CJ, Jordan R, Oncogene 2003 22 5093 107 10.1038/sj.onc.1206557 12910247 (Pubitemid 37059591)
3. Hepatocellular carcinoma. Marrero JA, Curr Opin Gastroenterol 2006 22 248 53 10.1097/01.mog.0000218961.86182.8c 16550039 (Pubitemid 44090061)
4. Viral hepatitis and hepatocellular carcinoma. Sallie R, Di Bisceglie AM, Gastroenterol Clin North Am 1994 23 567 79 7989095 (Pubitemid 24283700)
5. Chronic hepatitis B. Lok A, McMahon B, Hepatology 2001 34 1225 41 10.1053/jhep.2001.29401 11732013 (Pubitemid 33096596)
6. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. El Serag HB, Mason AC, Key C, Hepatology 2001 33 62 65 10.1053/jhep.2001.21041 11124821 (Pubitemid 32016888)
7. Risk factors for hepatocellular carcinoma in patients with cirrhosis. Sarbah SA, Gramlich T, Younoszai A, Osmack P, Goormastic M, Grosso L, Cooper JN, Di Bisceglie A, Seneca R, Younossi ZM, Dig Dis Sci 2004 49 850 3 15259508 (Pubitemid 38870213)
8. alpha fetogloblin in the diagnosis of human hepatoma. Alpert ME, Uriel J, de Nechaud B, N Engl J Med 1968 278 984 6 10.1056/NEJM196805022781804 4171303
9. Serum alpha-fetoprotein: diagnostic significance in liver disease. Ruoslahti E, Salaspuro M, Pihko H, Andersson L, Seppala M, Br Med J 1974 2 527 9 10.1136/bmj.2.5918.527 4407283
10. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Di Bisceglie AM, Hoofnagle JH, Cancer 1989 64 2117 20 10.1002/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7 2478280 (Pubitemid 19280413)
11. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Sherman M, Semin Liver Dis 2005 25 143 54 10.1055/s-2005-871194 15918143 (Pubitemid 40781067)
12. Glycosylation: heterogeneity and the 3D structure of proteins. Rudd PM, Dwek RA, Crit Rev Biochem Mol Biol 1997 32 1 100 10.3109/10409239709085144 9063619 (Pubitemid 27131666)
13. Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor. Aoyagi Y, Suzuki Y, Igarashi K, Yokota T, Mori S, Suda T, Naitoh A, Isemura M, Asakura H, Cancer 1993 72 615 8 10.1002/1097-0142(19930715)72: 2<615::AID-CNCR2820720246>3.0.CO;2-T 7686444 (Pubitemid 23193476)
14. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma. Naitoh A, Aoyagi Y, Asakura H, J Gastroenterol Hepatol 1999 14 436 45 10355508 (Pubitemid 29256179)
15. The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma. Aoyagi Y, Isokawa O, Suda T, Watanabe M, Suzuki Y, Asakura H, Cancer 1998 83 2076 82 10.1002/(SICI)1097- 0142(19981115)83:10<2076::AID-CNCR5>3.0.CO;2-L 9827711 (Pubitemid 28525388)
16. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines. Noda K, Miyoshi E, Gu J, Gao CX, Nakahara S, Kitada T, Honke K, Suzuki K, Yoshihara H, Yoshikawa K, Kawano K, Tonetti M, Kasahara A, Hori M, Hayashi N, Taniguchi N, Cancer Res 2003 63 6282 9 14559815 (Pubitemid 37255175)
17. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fimmel C, Tennant BC, London WT, Evans AA, Blumberg BS, Dwek RA, Mattu TS, Mehta AS, Proc Natl Acad Sci USA 2005 102 779 84 10.1073/pnas.0408928102 15642945 (Pubitemid 40282742)
18. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. Comunale MA, Lowman M, Long RE, Krakover J, Philip R, Seeholzer S, Evans AA, Hann HWL, Block TM, Mehta AS, Journal of Proteome Research 2006 6 308 315 (Pubitemid 43224256)
19. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Drake RR, Schwegler EE, Malik G, Diaz J, Block T, Mehta A, Semmes OJ, Mol Cell Proteomics 2006 5 1957 67 10.1074/mcp.M600176-MCP200 16760258 (Pubitemid 44688203)
20. Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Wang M, Long RE, Comunale MA, Junaidi O, Marrero J, Di Bisceglie AM, Block TM, Mehta AS, Cancer Epidemiol Biomarkers Prev 2009 18 1914 21 10.1158/1055-9965.EPI-08-0980 19454616
21. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM, J Hepatol 2005 43 1007 12 10.1016/j.jhep.2005.05.028 16137783 (Pubitemid 41627986)
22. Penalized logistic regression for detecting gene interaction. Park MY, Hastie T, Biostatistics 2008 9 1 30 50 10.1093/biostatistics/kxm010 17429103 (Pubitemid 350274580)
23. Park MY, Hastie T, Package 'stepPlr' 2009 http://www.r-project.org version 0.92 24072754
24. Unbiased recursive partitioning: A conditional inference framework. Hothorn T, Hornik K, Zeileis A, Journal of Computational and Graphical statistics 2006 15 3 651 674 10.1198/106186006X133933 (Pubitemid 44554201)
25. Package 'party': A laboratory for recursive partitioning. Hothorn T, Hornik K, Strobl C, Zeileis A, 2011 http://www.r-project.org version 0.9-99995
26. Improved biomarker performance for the detection of hepatocellular carcinoma by inclusion of clinical parameters. Wang M, Block TM, Marrero J, Di Bisceglie AM, Devarajan K, Mehta A, Bioinformatics and Biomedicine (BIBM), 2012 IEEE International Conference on: 4-7 October 2012 2012 1 5 10.1109/BIBM.2012. 6392612